In virtually all populations, 21-hydroxylase deficiency (21-OHD, CYP21A2) is most prevalent, with an incidence of 1:10,000–1:20,000 (although geographical hotspots occur) (32, 33). The gene discussed is CYP21A2; the disease is classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.